Buying beaten down biotech stocks is a strategy I focus on, especially at the end of each year because as tax loss selling fades, it is possible to see very strong gains into the New Year. For example, last December, I wrote an article about Immunogen (IMGN) titled “Why This $1 Biotech Stock Is A Strong Buy Now” and that stock went to over $8.50 per share in 2017. Almost a year ago,....More>>>
“Wanna get away?” The catchy Southwest Airlines Co (NYSE:LUV) slogan perfectly matches the mood at Tesla Inc (NASDAQ:TSLA). Long Wall Street’s poster child, TSLA stock is recently giving even the most hardened bulls some pause. Although company shares are up a meteoric 50% year-to-date, it has been less impressive after loosely flirting with the $400 mark.
This Top Pick for 2017 may very well have the best and broadest early-stage oncology pipeline with 12 drug development candidates, suggests Jay Silverman, editor The Medical Technology Stock Letter.
Incyte (INCY) is poised for a strong performance in 2017 that will be driven by three major catalysts.
The first is that the firm’s drug Jakafi will continue to be a compelling....More>>>
Westlake Village, CA, based Investment company West Oak Capital, LLC buys Amazon.com Inc, Cisco Systems Inc, iRobot Corp, Equity Residential, Comerica Inc, Cannae Holdings Inc, Vornado Realty Trust, Avery Dennison Corp, Owens-Corning Inc, Dollar Tree Inc, sells Vanguard Short-Term Corporate Bond ETF, General Electric Co, AbbVie Inc, Schwab U.S. Large-Cap, Guggenheim S&P 500 Equal Weight during....More>>>
Will Bitcoin Fever Push 2018 Price to $20,000? $100,000?
14 of the Best 529 College Savings Plans: 2017
FINRA Releases First Exam Findings Report
Leading economists at U.S financial firms don’t expect the final tax cut plan will have much impact on U.S. economic growth, according to SIFMA’s economic outlook survey for 2018. Eighty percent of the 25 chief and senior....More>>>
Shareholders in Gilead Sciences (NASDAQ:GILD) don’t seem to be able to catch a break from bad news and the stock’s underperformance, but we believe recent events have finally put enough pressure on management to make an acquisition and to redeploy the cash on its balance sheet on a strategic acquisition. Though there are many possible targets, we believe the answer to Gilead’s....More>>>
403(b) plans aren’t as well-known as other tax-favored retirement accounts, such as 401(k) plans or IRAs. But for teachers and many public-sector employees, employers often offer 403(b) plans as a way to save for retirement. With the same contribution limits as 401(k)s, 403(b) accounts can go a long way toward meeting your retirement needs. But to take maximum advantage of 403(b)s, you have....More>>>
Clinical stage biopharmaceutical company Biohaven Pharmaceuticals (Pending:BHVN) has filed to raise $125 million in an IPO by selling 8.33 million common shares at a midpoint price of $15.00 per share.
Biohaven has a large pipeline of treatments under development for neurological conditions.
The company is in or nearing Phase 3 trials for its lead candidates,....More>>>
Rebekah Barsch is executive officer and vice president of Planning and Sales at Northwestern Mutual.
To save for a comfortable retirement, many people shoot for a number. If you’re one of them, and you’re diligently saving toward that goal, great! But it takes more than a commitment to your 401(k) to build a financially solid retirement. Along with how much you save, you need....More>>>
Amazon’s real growth strategy will continue to drive upside in AMZN stock for years to come.
Amazon’s(NSDQ:AMZN)growth inside and outside the United States has been relentless in the last ten years, and their double-digit growth has continued even after the company crossed over into the 100-billion-dollar annual sales territory. As the top line gets bigger and bigger, sustaining....More>>>